Source: Annual Congress 2012 - The smoking gun in COPD biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Nowinski, D. Korzybski, D. Kaminski, A. Stoklosa, D. Gorecka (Warsaw, Poland). COPD patients with more severe GOLD stages have higher serum cystatin C levels. Eur Respir J 2012; 40: Suppl. 56, 4583

Member's Comments

No comment yet.

Related content which might interest you: Serum TGF-β level in patients with different stages of stable COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Elevation of plasma cystatin C levels in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 583s Year: 2002 The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage Source: Eur Respir J 2004; 24: Suppl. 48, 63s Year: 2004 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Asthmatics with high levels of serum surfactant protein D have more severe disease Source: Eur Respir J 2016; 47:1864-1867 Year: 2016 Serum levels of IL-6 in adult patients with moderate to severe asthma. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 HDL serum levels are significantly lower in patients with COPD than in never-smokers Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Vitamin C level in the serum of smokers and non-smokers with COPD in stable state and during exacerbation Source: Eur Respir J 2007; 30: Suppl. 51, 556s Year: 2007 Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Dynamics of marker of inflammation - sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients. Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Content of adiponectin in blood of COPD patients depending on stage of disease and presence of emphysema Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017